News
-
-
COMMUNIQUÉ DE PRESSE
ElringKlinger Annual General Meeting approves unchanged dividend
ElringKlinger AG's Annual General Meeting approves unchanged dividend of EUR 0.15 per share and elects new Chairman of the Supervisory Board. CEO highlights robust business model and strategic positioning for future transformation -
COMMUNIQUÉ DE PRESSE
Adolore BioTherapeutics Announces Publication Demonstrating Carbonic Anhydrase-8 Gene Therapy (rdHSV-CA8) Decreased Pain-Sensing Neuronal Excitability by Activating Kv7 Voltage-Gated Potassium Channels
Adolore BioTherapeutics announces groundbreaking findings in gene therapy for chronic pain treatment, highlighting the value of non-opioid analgesics and progress with IND-enabling studies -
COMMUNIQUÉ DE PRESSE
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
XSeed Labs, a collaboration between BioMed X and Boehringer Ingelheim, forms a new research team to develop disease models focusing on wound healing and fibrosis, aiming to bridge research and drug development for improved patient outcomes -
-
COMMUNIQUÉ DE PRESSE
RAPPORT ANNUEL 2023
-
-
COMMUNIQUÉ DE PRESSE
DEXIS Innovation Continues With New DEXIS Ti2 Sensor as Successor to the DEXIS Titanium Sensor, the #1 Selling Intraoral Sensor in the United States
DEXIS launches the DEXIS Ti2 Sensor, a new addition to its digital ecosystem for dental imaging, featuring improved durability, AI Dental Findings, and proactive servicing. Visit booth 1665 at CDA South to experience the innovation -
COMMUNIQUÉ DE PRESSE
Teach Access Announces 2024-2025 Digital Accessibility Grant Winners
Teach Access Grants program supports educators in creating innovative course materials to develop a workforce skilled in technology usable by people with disabilities. Winners of 2024-2025 Grants program announced on Global Accessibility Awareness Day -
